TT/I  Venture Center

http://www.research.umn.edu/techcomm/venture- center.html





     Office Locations:

280 McNamara Alumni Center
200 Oak Street SE
Minneapolis, MN 55455
Phone: 612-624-0550

 

Stages:

  • Seed


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    The Office for Technology Commercialization (OTC) takes the ideas and technology that stem from University of Minnesota research, prepares this intellectual property for the market, and in some cases spins it out into new businesses. The Venture Center is the business unit within OTC that works with entrepreneurs, researchers, and investors to create start-up companies based on University research. The Venture Center also monitors and guides these start-ups until the occurrence of a liquidity event. The Center is capable of making an 'Ignition Investment,' which is an early stage loan made of $10,000 to $50,000 to a University start-up company to help enable a successful launch. The Ignition Investment will go directly to the company as a loan before the first outside money is raised for the company. Only new University of Minnesota start-ups are eligible to apply for Ignition Investments.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Doug Johnson Director
    Jay Schrankler Executive Director
    Justin Porter Associate
    Russ Straate Associate Director

     

    Portfolio companies include:


      Aria CV
        web link


      Ariel Pharmaceuticals
        web link


      Ascir
        web link


      BioCee
        web link


      Celladon
        web link


      Cellectis Plant Sciences
        web link


      Commerce and Search for Technology Transfer
        web link


      CycleWood Solutions
        web link


      Hennepin Life Sciences
        web link


      International Cardio
        web link


      Kingsbury Animal Health
        web link


      Medication Management Systems
        web link


      Orasi Medical
        web link


      VitalMedix
        web link


     

    Recent News: